To scroll text in this page
Global Navigation end
-
Global Corporate Brand Campaign
-
-
Company brochure is available in PDF.
-
Integrated with the CSR report.
-
Latest materials on IR are available here.
-
May 24, 2013
- Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan
-
May 23, 2013
- ASTELLAS RECEIVES MARKETING AUTHORISATION FOR VESOMNITM FROM THE NETHERLANDS MEDICINES EVALUATION BOARD (pdf 103KB)
-
May 16, 2013
- AVEO and Astellas Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting
-
May 15, 2013
- FDA APPROVES TARCEVA (ERLOTINIB) TABLETS AND COBAS EGFR MUTATION TEST FOR SPECIFIC TYPE OF LUNG CANCER
-
May 14, 2013
- Reshaping research framework to enhance the ability to generate innovative drugs
Main Text end
